Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.
Jinda Fan, Sarah M Brown, Zhude Tu, Evan D Kharasch
文献索引:Bioconjug. Chem. 22(4) , 752-8, (2011)
全文:HTML全文
摘要
Norbuprenorphine-3-β-d-glucuronide (nBPN-3-β-d-G, 1) is a major phase II metabolite of buprenorphine, a pharmaceutical used for the treatment of opioid addiction. The pharmacological activity of compound 1 is not clear because investigations have been limited by the lack of chemically pure, well characterized 1 in sufficient quantities for in vitro and in vivo experiments. This work describes two concise, new methods of synthesis of 1, a chemical and an enzyme-assisted synthesis. The chemical synthesis used a strategy based on a combination of Koenig-Knorr coupling and amino-silyl protection. The enzyme-assisted synthesis used dog liver to convert the substrate norbuprenorphine (nBPN, 2) to 1. Both methods provided 1, characterized by (1)H NMR and tandem mass spectrometry, with purity >96%. The fractional yield of the enzyme-assisted synthesis was greater than that of the chemical synthesis (67% vs 5.3%), but due to larger reaction volumes, the chemical synthesis afforded greater amounts of total 1.
相关化合物
相关文献:
2012-10-01
[J. Pharmacol. Exp. Ther. 343(1) , 53-61, (2012)]
2011-10-01
[Ther. Drug Monit. 33(5) , 619-26, (2011)]
2010-01-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(1) , 13-20, (2010)]
2010-05-01
[Int. J. Legal Med. 124(3) , 187-94, (2010)]
2012-03-01
[Biomed. Chromatogr. 26(3) , 358-62, (2012)]